Trial intelligence / Profile preview

Evaluation of Antiplatelet Drug Resistance in Taiwanese

NCT01023360Phase 4Unknown

Sponsor
National Taiwan University Hospital
Start
May 2008
Primary completion
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clopidogrel in stroke, coronary heart disease (CHD), sponsored by National Taiwan University Hospital. Status: unknown.

02

Drugs

clopidogrel
03

Conditions

strokecoronary heart disease (CHD)

Beyond the preview

Go deeper on NCT01023360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01023360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call